Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_assertion wasGeneratedBy ECO_0000203 NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_assertion wasDerivedFrom befree-20150227 NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_assertion SIO_000772 22123319 NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_assertion evidence source_evidence_literature NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.
- NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_assertion description "[Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in two phase III trials of patients with advanced melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452573.RAiDXXdFJ-M-QZRgVyC5kiZV84tCGo8qFhKQmXbeSS6zY130_provenance.